Search Results - "ALESSANDRINO, Emilio Paolo"
-
1
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel
Published in Blood (30-03-2017)“…An international expert panel, active within the European Society for Blood and Marrow Transplantation, European LeukemiaNet, Blood and Marrow Transplant…”
Get full text
Journal Article -
2
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial
Published in The lancet oncology (01-11-2015)“…Summary Background The standard busulfan–cyclophosphamide myeloablative conditioning regimen is associated with substantial non-relapse mortality in patients…”
Get full text
Journal Article -
3
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
Published in Blood (01-08-2008)“…We evaluated the impact of World Health Organization (WHO) classification and WHO classification–based Prognostic Scoring System (WPSS) on the outcome of…”
Get full text
Journal Article -
4
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study
Published in Haematologica (Roma) (01-03-2010)“…Transfusion-dependency affects the natural history of myelodysplastic syndromes. Secondary iron overload may concur to this effect. The relative impact of…”
Get full text
Journal Article -
5
Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection
Published in Haematologica (Roma) (01-02-2008)“…1 Servizio di Virologia and 2 Divisione di Ematologia, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy…”
Get full text
Journal Article -
6
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)
Published in Blood (15-11-2001)“…One hundred nine patients with hematologic malignancies, undergoing bone marrow transplants (BMT) from unrelated donors, were randomized in 2 consecutive…”
Get full text
Journal Article -
7
A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study
Published in Biology of blood and marrow transplantation (01-06-2018)“…•Favorable outcome of a modified PT-CY regimen, with cyclosporin given before PT-CY.•It is associated with a very low rate of relapse in remission patients.•We…”
Get full text
Journal Article -
8
Second Allogeneic Bone Marrow Transplantation in Acute Leukemia: Results of a Survey by the European Cooperative Group for Blood and Marrow Transplantation
Published in Journal of clinical oncology (15-08-2001)“…Leukemic relapse is the most frequent cause of treatment failure after allogeneic hematopoietic stem-cell transplantation (HSCT). To identify prognostic…”
Get full text
Journal Article -
9
Infection and Coinfection of Human Rhinovirus C in Stem Cell Transplant Recipients
Published in Clinical & developmental immunology (01-01-2013)“…In 54 adult stem cell transplant recipients, the presence and persistence of human rhinoviruses (including the novel lineage C) were evaluated by molecular…”
Get full text
Journal Article -
10
Limited feasibility of double transplant in multiple myeloma : Results of a multicenter study on 153 patients aged <65 years
Published in Cancer (01-06-2007)“…Although high-dose therapy is considered the standard therapy for younger patients with multiple myeloma (MM), the advantages of performing a second transplant…”
Get full text
Journal Article -
11
Persistent Symptomless Human Metapneumovirus Infection in Hematopoietic Stem Cell Transplant Recipients
Published in The Journal of infectious diseases (15-08-2006)“…Sequential nasopharyngeal aspirates from patients without respiratory symptoms undergoing hematopoietic stem cell transplantation (HSCT) were tested for…”
Get full text
Journal Article -
12
Thymoglobulin Prevents Chronic Graft-versus-Host Disease, Chronic Lung Dysfunction, and Late Transplant-Related Mortality: Long-Term Follow-Up of a Randomized Trial in Patients Undergoing Unrelated Donor Transplantation
Published in Biology of blood and marrow transplantation (01-05-2006)“…This is an update of a randomized study on antithymocyte globulin (ATG; Thymoglobulin) before transplantation in patients undergoing unmanipulated marrow…”
Get full text
Journal Article -
13
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R
Published in Blood (10-04-2014)“…Approximately one-third of patients with myelodysplastic syndrome (MDS) receiving allogeneic hematopoietic stem cell transplantation (HSCT) are cured by this…”
Get full text
Journal Article -
14
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
Published in Clinical infectious diseases (01-12-2017)“…Gram-negative bacteremia (GNB) is a major cause of illness and death after hematopoietic stem cell transplantation (HSCT), and updated epidemiological…”
Get full text
Journal Article -
15
Should cytoreductive treatment be performed before transplantation in patients with high-risk myelodysplastic syndrome?
Published in Journal of clinical oncology (20-07-2013)Get full text
Journal Article -
16
Comparing Costs Associated to Letermovir Prophylaxis Vs Ganciclovir Pre-Emptive Therapy in HCMV-Seropositive Patients Who Undergone to Hemopoietic Stem Cells Transplantation
Published in Blood (13-11-2019)“…INTRODUCTION: Human cytomegalovirus (HCMV) infection is a significant cause of mortality and morbidity after hemopoietic stem cell transplantation (HSCT)…”
Get full text
Journal Article -
17
Virological and Immunological Monitoring of Human Cytomegalovirus (HCMV) Infection in Hematopoietic Stem Cell Transplantation Recipients (HSCTR)
Published in Blood (13-11-2019)“…Introduction HCMV infection is a significant viral complication in HSCTR, causing either a subclinical infection or a severe disease (systemic syndrome and…”
Get full text
Journal Article -
18
Early T cell reconstitution and cytokine profile may help to guide a personalized management of human cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
Published in Journal of clinical virology (01-02-2021)“…[Display omitted] •Polyfunctional HCMV-specific CD8+T-cells control HCMV infection.•Early T-cell analysis may guide a personalized management of HCMV…”
Get full text
Journal Article -
19
Neurological Complications Involving the Central Nervous System After Allogeneic Hematopoietic Stem Cell Transplantation During a Period of Evolution in Transplant Modalities: A Cohort Analysis
Published in Transplantation (01-03-2017)“…BACKGROUNDNeurological complications (NC) after hematopoietic stem cell transplantation (HSCT) are rare events. The evolution of transplant procedures has…”
Get full text
Journal Article -
20
Human Cytomegalovirus-Specific T-Cell Reconstitution and Late-Onset Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantation Recipients following Letermovir Prophylaxis
Published in Transplantation and cellular therapy (01-04-2022)“…Letermovir (LTV), recently approved for the prophylaxis of human cytomegalovirus (HCMV) reactivation after hematopoietic stem cell transplantation (HSCT), has…”
Get full text
Journal Article